Don't miss the May issue of ACRP's Clinical Researcher featuring the article, "Lessons Learned from Conducting a Trial during a Pandemic," by Ryan Bailey, Senior...
The COVID-19 Pandemic
While this is a difficult time for so many, we in the drug development industry have the opportunity to turn the tide on this pandemic and bring relief to those who are suffering. Now, more than ever, we are committed to helping our clients with the development of COVID-related and other life-saving therapies while navigating this complex research landscape.
Experience Makes the Difference
Experience Makes the Difference
Helping sponsors get their cures approved and in the hands of those most in need is a true passion of ours, and getting it done in the context of a global pandemic is something we’ve done already. During the 2009 H1N1 pandemic, the NIH turned to Rho to rapidly develop and coordinate a national, multisite project to evaluate the immunogenicity and dosing of the H1N1 vaccine in those with asthma. Today, our experts are conducting clinical trials for COVID-related products, including an 8,000 patient study of Coronavirus infection rates in children. Learn more about how we can help you.
Our Expertise